Health

STAT+: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.

Source STAT Updated May 28, 2026 AI Summary

AI Summary

An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.

Read full article on Statnews

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence

SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow